World Psychiatry· 2025Q1· Review
Charting the evolution of artificial intelligence mental health chatbots from rule‐based systems to large language models: a systematic review
- 93citations
- Q1SCImago
- 2025year
Short summary
A systematic review of 160 studies (2020-2024) reveals that while large language model (LLM)-based mental health chatbots surged to 45% of new research in 2024, only 16% underwent clinical efficacy testing, with most studies still in early validation stages.
AI-generated from the title and abstract; the full text is not read.
Key points
- LLM-based mental health chatbots comprised 45% of new studies in 2024, up from previous years.
- Only 16% of LLM studies and 47% of all studies assessed clinical efficacy (symptom reduction).
- Many marketed "AI-powered" chatbots rely on simple rule-based scripts, not advanced AI.
- LLM chatbots raise ethical concerns including incorrect responses, privacy risks, and unverified effects.
- A proposed three-tier evaluation framework (bench, pilot, clinical) aims to standardize assessment.
AI-generated from the title and abstract; the full text is not read.
Abstract
The rapid evolution of artificial intelligence (AI) chatbots in mental health care presents a fragmented landscape with variable clinical evidence and evaluation rigor. This systematic review of 160 studies (2020-2024) classifies chatbot architectures - rule-based, machine learning-based, and large language model (LLM)-based - and proposes a three-tier evaluation framework: foundational bench testing (technical validation), pilot feasibility testing (user engagement), and clinical efficacy testing (symptom reduction). While rule-based systems dominated until 2023, LLM-based chatbots surged to 45% of new studies in 2024. However, only 16% of LLM studies underwent clinical efficacy testing, with most (77%) still in early validation. Overall, only 47% of studies focused on clinical efficacy testing, exposing a critical gap in robust validation of therapeutic benefit. Discrepancies emerged between marketed claims ("AI-powered") and actual AI architectures, with many interventions relying on simple rule-based scripts. LLM-based chatbots are increasingly studied for emotional support and psychoeducation, yet they pose unique ethical concerns, including incorrect responses, privacy risks, and unverified therapeutic effects. Despite their generative capabilities, LLMs remain largely untested in high-stakes mental health contexts. This paper emphasizes the need for standardized evaluation and benchmarking aligned with medical AI certification to ensure safe, transparent and ethical deployment. The proposed framework enables clearer distinctions between technical novelty and clinical efficacy, offering clinicians, researchers and regulators ordered steps to guide future standards and benchmarks. To ensure that AI chatbots enhance mental health care, future research must prioritize rigorous clinical efficacy trials, transparent architecture reporting, and evaluations that reflect real-world impact rather than the well-known potential.
The authors' abstract, as published at the source. World Psychiatry, 2025 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Applied Psychology
Applied PsychologyPsychology